5
Total investments
3
Early stage
0
Mid stage
0
Late stage
12y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Mar 2016
Lumiode is a fabless semiconductor company commercializing a novel micro-LED platform delivering ultra-high brightness, low power, small form factor displays. As a leading developer of fully integrated micro-LED displays, Lumiode’s solutions are well suited for AR/VR (Augmented Reality/Virtual Reality), HUD (Head-Up Display) and projection applications.
Lumiode is headquartered in New York City.
Investor
2016
Chip Diagnostics is commercializing an innovative hardware and data/AI informatics platform, used to develop novel, exosome-based biomarker signatures for early disease diagnostics and therapy management.
We developed a proprietary workflow to rapidly scan blood samples for trillions of exosomes individually to identify and interpret organ-specific exosome populations.
Our solutions enable extremely accurate “fingerprinting” of a broad range of diseases and their states, offering inexpensive, and less time and resource-intensive workflows across biopharma/drug discovery and diagnostics use cases.
Founding Investor
2015
MOBILion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies.
Investor, Board
Dec 2014
Exyn Technologies was established in 2014 to commercialize decades of ground-breaking research in aerial robotics, drone swarms, multi-modal sensor fusion, 3D mapping, obstacle avoidance, and autonomous navigation & planning.
Exyns focus is on developing software for aerial robots so they can operate in GPS-denied environments, without human control, prior information, or pre-existing infrastructure (e.g. no motion capture system).
Our approach to client engagement is to be a partner and jointly solve problems. We engage with clients in all parts of the value chain (solutions providers to end-users) across various industries.
We are a spin-out from the University of Pennsylvania GRASP Labs under the direction of Professor Vijay Kumar. Our team is comprised of industrial and academic leaders in aerial robotics.
Experience · 9 entries
All (9)
Investments (5)
Founder (1)
2016
Investor
Mar 2016
Lumiode is a fabless semiconductor company commercializing a novel micro-LED platform delivering ultra-high brightness, low power, small form factor displays. As a leading developer of fully integrated micro-LED displays, Lumiode’s solutions are well suited for AR/VR (Augmented Reality/Virtual Reality), HUD (Head-Up Display) and projection applications.
Lumiode is headquartered in New York City.
Investor
2016
Chip Diagnostics is commercializing an innovative hardware and data/AI informatics platform, used to develop novel, exosome-based biomarker signatures for early disease diagnostics and therapy management.
We developed a proprietary workflow to rapidly scan blood samples for trillions of exosomes individually to identify and interpret organ-specific exosome populations.
Our solutions enable extremely accurate “fingerprinting” of a broad range of diseases and their states, offering inexpensive, and less time and resource-intensive workflows across biopharma/drug discovery and diagnostics use cases.
2015
U
Uniformity Labs
Investor
Jun 2015
Founding Investor
2015
MOBILion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies.
2014
Investor, Board
Dec 2014
Exyn Technologies was established in 2014 to commercialize decades of ground-breaking research in aerial robotics, drone swarms, multi-modal sensor fusion, 3D mapping, obstacle avoidance, and autonomous navigation & planning.
Exyns focus is on developing software for aerial robots so they can operate in GPS-denied environments, without human control, prior information, or pre-existing infrastructure (e.g. no motion capture system).
Our approach to client engagement is to be a partner and jointly solve problems. We engage with clients in all parts of the value chain (solutions providers to end-users) across various industries.
We are a spin-out from the University of Pennsylvania GRASP Labs under the direction of Professor Vijay Kumar. Our team is comprised of industrial and academic leaders in aerial robotics.
Show all 9 entries ↓
Investment activity
2014–2016 · 5 investments
Recent (last 2 years)Earlier
